Divi's Laboratories Limited is a leading Indian pharmaceutical company that specializes in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company has a strong focus on research, technology, and innovation to deliver high-quality products for global markets.

The company's product portfolio includes various APIs across therapeutic segments such as anti-hypertensives, lipid-lowering agents, anti-fungals, anti-virals, central nervous system drugs, and more. Divi's Laboratories also offers custom synthesis of APIs and advanced intermediates for its clients worldwide.

One of the key factors that make Divi's Laboratories stand out from its competitors is its commitment to excellence in manufacturing processes. The company operates state-of-the-art manufacturing facilities that comply with international quality standards. This emphasis on quality control has resulted in numerous regulatory approvals from prominent health authorities like the US Food and Drug Administration (FDA), European Directorate for Quality Medicines (EDQM), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, among others.

Divi's Laboratories leverages innovative technologies in its production processes to ensure efficiency while maintaining stringent quality standards. The company invests significantly in research & development to stay at the forefront of technological advancements within the industry.

In terms of partnerships and collaborations, Divi's Laboratories has strategic alliances with several global pharma companies for contract manufacturing services as well as joint research initiatives. These partnerships have further strengthened the company’s position as a reliable supplier of high-quality APIs globally.